Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 133, Issue 15
April 11 2019
Issue Cover

Table of Contents

BLOOD COMMENTARIES

MYELOID NEOPLASIA
I myelofibrosis! Veni VitD! Et tu, macrophage?
Ashley P. Ng
View Articletitled, I myelofibrosis! Veni VitD! Et tu, macrophage?
CLINICAL TRIALS AND OBSERVATIONS
Congenital TTP: toward a turning point
Clinical Trials & Observations
James N. George
View Articletitled, Congenital TTP: toward a turning point
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Running the tank to empty: how far can the CAR go?
Sumithira Vasu,Samantha M. Jaglowski
View Articletitled, Running the tank to empty: how far can the CAR go?

PLENARY PAPER

MYELOID NEOPLASIA
Vitamin D receptor–mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis
Kanako Wakahashi,Kentaro Minagawa,Yuko Kawano,Hiroki Kawano,Tomohide Suzuki,Shinichi Ishii,Akiko Sada,Noboru Asada,Mari Sato,Shigeaki Kato,Kotaro Shide,Kazuya Shimoda,Toshimitsu Matsui,Yoshio Katayama
View Articletitled, Vitamin D receptor–mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis
Supplemental data

SPECIAL REPORT

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Clinical Trials & Observations
Miguel A. Sanz,Pierre Fenaux,Martin S. Tallman,Elihu H. Estey,Bob Löwenberg,Tomoki Naoe,Eva Lengfelder,Hartmut Döhner,Alan K. Burnett,Sai-Juan Chen,Vikram Mathews,Harry Iland,Eduardo Rego,Hagop Kantarjian,Lionel Adès,Giuseppe Avvisati,Pau Montesinos,Uwe Platzbecker,Farhad Ravandi,Nigel H. Russell,Francesco Lo-Coco
View Articletitled, Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

CLINICAL TRIALS AND OBSERVATIONS

Characterization and treatment of congenital thrombotic thrombocytopenic purpura
Clinical Trials & Observations
Ferras Alwan,Chiara Vendramin,Ri Liesner,Amanda Clark,William Lester,Tina Dutt,William Thomas,Richard Gooding,Tina Biss,H. G. Watson,Nichola Cooper,Rachel Rayment,Tanya Cranfield,Joost J. van Veen,Quentin A. Hill,Sarah Davis,Jayashree Motwani,Neha Bhatnagar,Nicole Priddee,Marianna David,Maeve P. Crowley,Jayanthi Alamelu,Hamish Lyall,John-Paul Westwood,Mari Thomas,Marie Scully

There is a Blood Commentary on this article in this issue.

View Articletitled, Characterization and treatment of congenital thrombotic thrombocytopenic purpura

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy
Clinical Trials & Observations
Kevin A. Hay,Jordan Gauthier,Alexandre V. Hirayama,Jenna M. Voutsinas,Qian Wu,Daniel Li,Ted A. Gooley,Sindhu Cherian,Xueyan Chen,Barbara S. Pender,Reed M. Hawkins,Aesha Vakil,Rachel N. Steinmetz,Gary Schoch,Aude G. Chapuis,Brian G. Till,Hans-Peter Kiem,Jorge D. Ramos,Mazyar Shadman,Ryan D. Cassaday,Utkarsh H. Acharya,Stanley R. Riddell,David G. Maloney,Cameron J. Turtle
View Articletitled, Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy
Supplemental data

LYMPHOID NEOPLASIA

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
Tayla B. Heavican,Alyssa Bouska,Jiayu Yu,Waseem Lone,Catalina Amador,Qiang Gong,Weiwei Zhang,Yuping Li,Bhavana J. Dave,Maarja-Liisa Nairismägi,Timothy C. Greiner,Julie Vose,Dennis D. Weisenburger,Cynthia Lachel,Chao Wang,Kai Fu,Jadd M. Stevens,Soon Thye Lim,Choon Kiat Ong,Randy D. Gascoyne,Edoardo Missiaglia,Francois Lemonnier,Corinne Haioun,Sylvia Hartmann,Martin Bjerregård Pedersen,Maria Antonella Laginestra,Ryan A. Wilcox,Bin Tean Teh,Noriaki Yoshida,Koichi Ohshima,Masao Seto,Andreas Rosenwald,German Ott,Elias Campo,Lisa M. Rimsza,Elaine S. Jaffe,Rita M. Braziel,Francesco d’Amore,Giorgio Inghirami,Francesco Bertoni,Laurence de Leval,Philippe Gaulard,Louis M. Staudt,Timothy W. McKeithan,Stefano Pileri,Wing C. Chan,Javeed Iqbal
View Articletitled, Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
Supplemental data

MYELOID NEOPLASIA

CDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networks
Iris Z. Uras,Barbara Maurer,Harini Nivarthi,Philipp Jodl,Karoline Kollmann,Michaela Prchal-Murphy,Jelena D. Milosevic Feenstra,Markus Zojer,Sabine Lagger,Reinhard Grausenburger,Beatrice Grabner,Raimund Holly,Anoop Kavirayani,Christoph Bock,Heinz Gisslinger,Peter Valent,Robert Kralovics,Veronika Sexl
View Articletitled, CDK6 coordinates <em>JAK2</em><sup><em>V617F</em></sup> mutant MPN via NF-κB and apoptotic networks
Supplemental data

LETTER TO BLOOD

Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition
Clinical Trials & Observations
Olive S. Eckstein,Johannes Visser,Carlos Rodriguez-Galindo,Carl E. Allen,the NACHO-LIBRE Study Group
View Articletitled, Clinical responses and persistent <em>BRAF</em> V600E<sup>+</sup> blood cells in children with LCH treated with MAPK pathway inhibition
Supplemental data

BLOOD WORK

Immune dysregulation: EBV+ DLBCL and HLH in a patient with T-LGL
Yougen Zhan,Julie Teruya-Feldstein
View Articletitled, Immune dysregulation: EBV<sup>+</sup> DLBCL and HLH in a patient with T-LGL
When nucleated RBCs “count” in the peripheral blood: a unique case of post–essential thrombocythemia myelofibrosis
Misty Thompson,David Lynch
View Articletitled, When nucleated RBCs “count” in the peripheral blood: a unique case of post–essential thrombocythemia myelofibrosis
All Issues

Advertisement intended for health care professionals

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19
The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals